Haemonetics's total assets for Q3 2026 were $2.49B, an increase of 2.00% from the previous quarter. HAE total liabilities were $1.58B for the fiscal quarter, a -0.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.